Hexapropymate Self-Poisoning Causes Severe and Long-Lasting Clinical Symptoms

  • L. L. Gustafsson
  • A. Berg
  • A. Magnusson
  • H. O. Malmlund
  • B. M. Sandell
  • R. Stig
Case Report Toxicology Experience Report

Summary

Cases of hexapropymate poisoning requiring intensive care in an urban region of Sweden (420,000 inhabitants) were collected over 2.5 years (1985 to 1987). Only patients with serum hexapropymate concentrations above 5.5 mg/L (30 μmol/L) and with a negative history for intake of tricyclic antidepressants, phenothiazines, barbiturates, antihistaminic drugs and opiates were included. Clinical data about 8 intoxication events in 6 patients were evaluated retrospectively. Initial symptoms included coma, hypotension, hypothermia, and hypoventilation. Maximum coma depth (Glasgow coma score) was 3 to 5 in 5 out of 8 events. On 7 occasions assisted ventilation was required (for 12 hours or more in 5 events). There was no relationship between serum concentrations of hexapropymate and severity of clinical symptoms. All patients survived. Detailed analysis of the drug elimination in one patient showed a terminal elimination half life of 21 hours, which is longer than previously reported (5 hours). The indications for use of this hypnotic drug may vary between doctors since an 8- fold variation was seen in drug prescription between Swedish counties in 1987. Poisoning with hexapropymate is a serious condition which may require symptomatic treatment in the intensive care unit. The clinical picture is similar to that seen in patients with burbiturate intoxication. There is no role for active forced elimination of the drug. It is questionable whether the clinical value of the drug is outweighed by its toxicity.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alván G. Plasma concentrations and effects of methaqualone after single and multiple oral doses in man. European Journal of Clinical Pharmacology 7: 449–454, 1974PubMedCrossRefGoogle Scholar
  2. Alván G, Lindgren JE, Bogentoft CE, Ericsson Ö. Plasma kinetics of methaqualone in man after single oral doses. European Journal of Clinical Pharmacology 6: 187–198, 1973PubMedCrossRefGoogle Scholar
  3. Bergman U, Elmes P, Halse M, Halvarsen T, Hood H, et al. The measurement of drug consumption: drugs for diabetes in Northern Ireland, Norway and Sweden. European Journal of Clinical Pharmacology 8: 83–89, 1975PubMedCrossRefGoogle Scholar
  4. Bonnichsen R, Holmgren P. A report on autopsy cases involving hexapropymate. Archivio di Medicina Legale, Sociale e Criminologia 10: 1–8, 1974Google Scholar
  5. de Silva JA, Bekersky I, Puglisi CV, Brooks MA, Weinfeld RE. Determination of 1.4-benzodiazepins and -diazepin-2-ones in blood by electron-capture gas-liquid chromatography. Analytical Chemistry 48: 10–19, 1976PubMedCrossRefGoogle Scholar
  6. Furst DE, Tozer TN, Melmon KL. Salicylate clearance, the resultant of protein binding and metabolism. Clinical Pharmacology and Therapeutics 26: 380–389, 1979PubMedGoogle Scholar
  7. Gary NE, Tresnewsky O. Clinical aspects of drug intoxication: barbiturates and a potpourri of other sedatives, hypnotics, and tranquilizers. Heart and Lung 12: 122–127, 1983PubMedGoogle Scholar
  8. Hassoun A, von Birst P, Vandendriessche M. Une méthode simple et rapide pour la recherche et le dosage de l’hexapropymate dans les milieux biologiques et les organes. Toxicol Eur Research 1: 185–188, 1978Google Scholar
  9. Höjer J, Baehrendtz S. The effect of flumazenil (Ro 15-1788) in the management of self-induced benzodiazepine poisoning: a double-blind controlled study. Acta Medica Scandinavica 227: 357–365, 1988Google Scholar
  10. Levy G, Tsuchiya T. Salicylate accumulation kinetics in man. New England Journal of Medicine 287: 730–732, 1972CrossRefGoogle Scholar
  11. Noirfalise A. Cinq cas de suspicion d’intoxication par l’hexapropvmate. European Journal of Toxicology 4: 50–52, 1971PubMedGoogle Scholar
  12. Pedersen OL, Gram LF, Kristensen CB, Möller M, Thayssen P, et al. Overdosage of antidepressants: clinical and pharmaco-kinetic aspects. European Journal of Clinical Pharmacology 23: 513–521, 1982PubMedCrossRefGoogle Scholar
  13. Robbins G, Brown AK. Hexapropymate self-poisoning. British Medical Journal 1: 1593, 1978PubMedCrossRefGoogle Scholar
  14. Vessman J, Johansson M, Magnusson P, Strömberg S. Determination of intact oxazepam by electron capture gas chroma-tography after an extractive alkylation reaction. Analytical Chemistry 4: 1545–1549, 1977CrossRefGoogle Scholar
  15. Weinfeld RE, Posmanter HN, Khoo KC, Puglisi CV. Rapid determination of diazepam and nondiazepam in plasma by electron capture gas-liquid chromatography: application in clinical pharmacokinetic studies. Journal of Chromatography 143: 581–595, 1977PubMedCrossRefGoogle Scholar

Copyright information

© ADIS Press Limited 1989

Authors and Affiliations

  • L. L. Gustafsson
    • 1
    • 2
  • A. Berg
    • 2
  • A. Magnusson
    • 2
  • H. O. Malmlund
    • 3
  • B. M. Sandell
    • 2
  • R. Stig
    • 4
  1. 1.Department of Clinical Pharmacology, Karolinska InstituteHuddinge University HospitalHuddingeSweden
  2. 2.Department of Clinical ChemistrySouth HospitalStockholmSweden
  3. 3.Department of Medicine ISouth HospitalStockholmSweden
  4. 4.Department of MedicineNacka HospitalNackaSweden

Personalised recommendations